nodes	percent_of_prediction	percent_of_DWPC	metapath
Granisetron—CYP1A1—head and neck cancer	0.724	1	CbGaD
Granisetron—CYP2D6—Hydroxyurea—head and neck cancer	0.0874	0.446	CbGbCtD
Granisetron—CYP3A5—Docetaxel—head and neck cancer	0.0416	0.212	CbGbCtD
Granisetron—CYP2D6—Vinblastine—head and neck cancer	0.0309	0.158	CbGbCtD
Granisetron—CYP3A4—Vinblastine—head and neck cancer	0.0197	0.1	CbGbCtD
Granisetron—CYP3A4—Docetaxel—head and neck cancer	0.0162	0.0828	CbGbCtD
Granisetron—Coma hepatic—Docetaxel—head and neck cancer	0.00565	0.0706	CcSEcCtD
Granisetron—Application site pain—Fluorouracil—head and neck cancer	0.00223	0.0279	CcSEcCtD
Granisetron—Ileus—Vinblastine—head and neck cancer	0.00211	0.0264	CcSEcCtD
Granisetron—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00144	0.018	CcSEcCtD
Granisetron—Leukocytosis—Fluorouracil—head and neck cancer	0.00104	0.0131	CcSEcCtD
Granisetron—Ileus—Docetaxel—head and neck cancer	0.001	0.0125	CcSEcCtD
Granisetron—Angina pectoris—Vinblastine—head and neck cancer	0.000913	0.0114	CcSEcCtD
Granisetron—Coma—Fluorouracil—head and neck cancer	0.000896	0.0112	CcSEcCtD
Granisetron—Photosensitivity—Fluorouracil—head and neck cancer	0.000811	0.0101	CcSEcCtD
Granisetron—Dysuria—Hydroxyurea—head and neck cancer	0.0008	0.01	CcSEcCtD
Granisetron—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.000779	0.00974	CcSEcCtD
Granisetron—Oliguria—Docetaxel—head and neck cancer	0.000768	0.00961	CcSEcCtD
Granisetron—Drug interaction—Docetaxel—head and neck cancer	0.000763	0.00955	CcSEcCtD
Granisetron—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000721	0.00902	CcSEcCtD
Granisetron—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000712	0.00891	CcSEcCtD
Granisetron—Hepatocellular injury—Docetaxel—head and neck cancer	0.000708	0.00886	CcSEcCtD
Granisetron—Fluid retention—Docetaxel—head and neck cancer	0.000672	0.00841	CcSEcCtD
Granisetron—Alopecia—Vinblastine—head and neck cancer	0.000663	0.00829	CcSEcCtD
Granisetron—Angiopathy—Hydroxyurea—head and neck cancer	0.000621	0.00777	CcSEcCtD
Granisetron—Chills—Hydroxyurea—head and neck cancer	0.000614	0.00768	CcSEcCtD
Granisetron—Eosinophilia—Fluorouracil—head and neck cancer	0.000609	0.00762	CcSEcCtD
Granisetron—Ill-defined disorder—Vinblastine—head and neck cancer	0.000606	0.00758	CcSEcCtD
Granisetron—Alopecia—Hydroxyurea—head and neck cancer	0.000605	0.00756	CcSEcCtD
Granisetron—Anaemia—Vinblastine—head and neck cancer	0.000604	0.00755	CcSEcCtD
Granisetron—Angina pectoris—Fluorouracil—head and neck cancer	0.0006	0.0075	CcSEcCtD
Granisetron—Malaise—Vinblastine—head and neck cancer	0.000589	0.00737	CcSEcCtD
Granisetron—Vertigo—Vinblastine—head and neck cancer	0.000587	0.00734	CcSEcCtD
Granisetron—Leukopenia—Vinblastine—head and neck cancer	0.000585	0.00731	CcSEcCtD
Granisetron—Hypertension—Vinblastine—head and neck cancer	0.000564	0.00705	CcSEcCtD
Granisetron—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000562	0.00703	CcSEcCtD
Granisetron—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000553	0.00691	CcSEcCtD
Granisetron—Anaemia—Hydroxyurea—head and neck cancer	0.000551	0.00689	CcSEcCtD
Granisetron—Discomfort—Vinblastine—head and neck cancer	0.00055	0.00687	CcSEcCtD
Granisetron—Atrial fibrillation—Docetaxel—head and neck cancer	0.000542	0.00678	CcSEcCtD
Granisetron—Malaise—Hydroxyurea—head and neck cancer	0.000537	0.00672	CcSEcCtD
Granisetron—Urinary tract infection—Fluorouracil—head and neck cancer	0.000533	0.00667	CcSEcCtD
Granisetron—Leukopenia—Hydroxyurea—head and neck cancer	0.000533	0.00667	CcSEcCtD
Granisetron—Thrombocytopenia—Vinblastine—head and neck cancer	0.000522	0.00653	CcSEcCtD
Granisetron—Epistaxis—Fluorouracil—head and neck cancer	0.000518	0.00647	CcSEcCtD
Granisetron—Hyponatraemia—Docetaxel—head and neck cancer	0.000516	0.00645	CcSEcCtD
Granisetron—Sinusitis—Fluorouracil—head and neck cancer	0.000515	0.00644	CcSEcCtD
Granisetron—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000514	0.00643	CcSEcCtD
Granisetron—Migraine—Docetaxel—head and neck cancer	0.000506	0.00633	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000504	0.0063	CcSEcCtD
Granisetron—Discomfort—Hydroxyurea—head and neck cancer	0.000501	0.00627	CcSEcCtD
Granisetron—Rhinitis—Fluorouracil—head and neck cancer	0.000494	0.00618	CcSEcCtD
Granisetron—Oedema—Hydroxyurea—head and neck cancer	0.000486	0.00608	CcSEcCtD
Granisetron—Infection—Hydroxyurea—head and neck cancer	0.000483	0.00604	CcSEcCtD
Granisetron—Paraesthesia—Vinblastine—head and neck cancer	0.000479	0.00599	CcSEcCtD
Granisetron—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000477	0.00596	CcSEcCtD
Granisetron—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000476	0.00595	CcSEcCtD
Granisetron—Liver function test abnormal—Docetaxel—head and neck cancer	0.000475	0.00593	CcSEcCtD
Granisetron—Skin disorder—Hydroxyurea—head and neck cancer	0.000472	0.00591	CcSEcCtD
Granisetron—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000469	0.00587	CcSEcCtD
Granisetron—Decreased appetite—Vinblastine—head and neck cancer	0.000463	0.0058	CcSEcCtD
Granisetron—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000463	0.00579	CcSEcCtD
Granisetron—Constipation—Vinblastine—head and neck cancer	0.000456	0.0057	CcSEcCtD
Granisetron—Pain—Vinblastine—head and neck cancer	0.000456	0.0057	CcSEcCtD
Granisetron—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000453	0.00567	CcSEcCtD
Granisetron—Arrhythmia—Fluorouracil—head and neck cancer	0.00044	0.0055	CcSEcCtD
Granisetron—Feeling abnormal—Vinblastine—head and neck cancer	0.000439	0.00549	CcSEcCtD
Granisetron—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000436	0.00545	CcSEcCtD
Granisetron—Alopecia—Fluorouracil—head and neck cancer	0.000435	0.00544	CcSEcCtD
Granisetron—Dyspnoea—Hydroxyurea—head and neck cancer	0.000433	0.00542	CcSEcCtD
Granisetron—Angina pectoris—Docetaxel—head and neck cancer	0.000433	0.00541	CcSEcCtD
Granisetron—Somnolence—Hydroxyurea—head and neck cancer	0.000432	0.00541	CcSEcCtD
Granisetron—Dyspepsia—Hydroxyurea—head and neck cancer	0.000428	0.00535	CcSEcCtD
Granisetron—Decreased appetite—Hydroxyurea—head and neck cancer	0.000423	0.00529	CcSEcCtD
Granisetron—Abdominal pain—Vinblastine—head and neck cancer	0.000421	0.00527	CcSEcCtD
Granisetron—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00042	0.00525	CcSEcCtD
Granisetron—Pain—Hydroxyurea—head and neck cancer	0.000416	0.0052	CcSEcCtD
Granisetron—Constipation—Hydroxyurea—head and neck cancer	0.000416	0.0052	CcSEcCtD
Granisetron—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000401	0.00501	CcSEcCtD
Granisetron—Anaemia—Fluorouracil—head and neck cancer	0.000396	0.00496	CcSEcCtD
Granisetron—Hypersensitivity—Vinblastine—head and neck cancer	0.000393	0.00491	CcSEcCtD
Granisetron—Jaundice—Docetaxel—head and neck cancer	0.000386	0.00483	CcSEcCtD
Granisetron—Body temperature increased—Hydroxyurea—head and neck cancer	0.000384	0.00481	CcSEcCtD
Granisetron—Leukopenia—Fluorouracil—head and neck cancer	0.000384	0.0048	CcSEcCtD
Granisetron—Asthenia—Vinblastine—head and neck cancer	0.000383	0.00478	CcSEcCtD
Granisetron—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000375	0.00468	CcSEcCtD
Granisetron—Epistaxis—Docetaxel—head and neck cancer	0.000374	0.00467	CcSEcCtD
Granisetron—Chest pain—Fluorouracil—head and neck cancer	0.000365	0.00457	CcSEcCtD
Granisetron—Diarrhoea—Vinblastine—head and neck cancer	0.000365	0.00456	CcSEcCtD
Granisetron—Discomfort—Fluorouracil—head and neck cancer	0.000361	0.00451	CcSEcCtD
Granisetron—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000358	0.00448	CcSEcCtD
Granisetron—Rhinitis—Docetaxel—head and neck cancer	0.000356	0.00446	CcSEcCtD
Granisetron—Dizziness—Vinblastine—head and neck cancer	0.000353	0.00441	CcSEcCtD
Granisetron—Oedema—Fluorouracil—head and neck cancer	0.00035	0.00438	CcSEcCtD
Granisetron—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00035	0.00438	CcSEcCtD
Granisetron—Connective tissue disorder—Docetaxel—head and neck cancer	0.000349	0.00437	CcSEcCtD
Granisetron—Asthenia—Hydroxyurea—head and neck cancer	0.000349	0.00436	CcSEcCtD
Granisetron—Infection—Fluorouracil—head and neck cancer	0.000348	0.00435	CcSEcCtD
Granisetron—Nervous system disorder—Fluorouracil—head and neck cancer	0.000343	0.00429	CcSEcCtD
Granisetron—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000343	0.00429	CcSEcCtD
Granisetron—Visual impairment—Docetaxel—head and neck cancer	0.000343	0.00429	CcSEcCtD
Granisetron—Tachycardia—Fluorouracil—head and neck cancer	0.000342	0.00427	CcSEcCtD
Granisetron—Vomiting—Vinblastine—head and neck cancer	0.000339	0.00424	CcSEcCtD
Granisetron—Headache—Vinblastine—head and neck cancer	0.000334	0.00418	CcSEcCtD
Granisetron—Diarrhoea—Hydroxyurea—head and neck cancer	0.000333	0.00416	CcSEcCtD
Granisetron—Flushing—Docetaxel—head and neck cancer	0.00033	0.00413	CcSEcCtD
Granisetron—Hypotension—Fluorouracil—head and neck cancer	0.000327	0.00409	CcSEcCtD
Granisetron—Angiopathy—Docetaxel—head and neck cancer	0.000323	0.00403	CcSEcCtD
Granisetron—Dizziness—Hydroxyurea—head and neck cancer	0.000322	0.00402	CcSEcCtD
Granisetron—Chills—Docetaxel—head and neck cancer	0.000319	0.00399	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000319	0.00399	CcSEcCtD
Granisetron—Arrhythmia—Docetaxel—head and neck cancer	0.000318	0.00397	CcSEcCtD
Granisetron—Nausea—Vinblastine—head and neck cancer	0.000317	0.00396	CcSEcCtD
Granisetron—Insomnia—Fluorouracil—head and neck cancer	0.000317	0.00396	CcSEcCtD
Granisetron—Paraesthesia—Fluorouracil—head and neck cancer	0.000314	0.00393	CcSEcCtD
Granisetron—Alopecia—Docetaxel—head and neck cancer	0.000314	0.00393	CcSEcCtD
Granisetron—Dyspnoea—Fluorouracil—head and neck cancer	0.000312	0.0039	CcSEcCtD
Granisetron—Somnolence—Fluorouracil—head and neck cancer	0.000311	0.00389	CcSEcCtD
Granisetron—Malnutrition—Docetaxel—head and neck cancer	0.00031	0.00387	CcSEcCtD
Granisetron—Vomiting—Hydroxyurea—head and neck cancer	0.000309	0.00387	CcSEcCtD
Granisetron—Dyspepsia—Fluorouracil—head and neck cancer	0.000308	0.00385	CcSEcCtD
Granisetron—Rash—Hydroxyurea—head and neck cancer	0.000307	0.00383	CcSEcCtD
Granisetron—Dermatitis—Hydroxyurea—head and neck cancer	0.000306	0.00383	CcSEcCtD
Granisetron—Headache—Hydroxyurea—head and neck cancer	0.000305	0.00381	CcSEcCtD
Granisetron—Decreased appetite—Fluorouracil—head and neck cancer	0.000304	0.00381	CcSEcCtD
Granisetron—Dysgeusia—Docetaxel—head and neck cancer	0.000303	0.00379	CcSEcCtD
Granisetron—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000302	0.00378	CcSEcCtD
Granisetron—Pain—Fluorouracil—head and neck cancer	0.000299	0.00374	CcSEcCtD
Granisetron—Nausea—Hydroxyurea—head and neck cancer	0.000289	0.00361	CcSEcCtD
Granisetron—Feeling abnormal—Fluorouracil—head and neck cancer	0.000288	0.00361	CcSEcCtD
Granisetron—Anaemia—Docetaxel—head and neck cancer	0.000286	0.00358	CcSEcCtD
Granisetron—Urticaria—Fluorouracil—head and neck cancer	0.000278	0.00348	CcSEcCtD
Granisetron—Syncope—Docetaxel—head and neck cancer	0.000278	0.00347	CcSEcCtD
Granisetron—Leukopenia—Docetaxel—head and neck cancer	0.000277	0.00347	CcSEcCtD
Granisetron—Body temperature increased—Fluorouracil—head and neck cancer	0.000277	0.00346	CcSEcCtD
Granisetron—Palpitations—Docetaxel—head and neck cancer	0.000274	0.00342	CcSEcCtD
Granisetron—Loss of consciousness—Docetaxel—head and neck cancer	0.000272	0.0034	CcSEcCtD
Granisetron—Cough—Docetaxel—head and neck cancer	0.00027	0.00338	CcSEcCtD
Granisetron—Hypertension—Docetaxel—head and neck cancer	0.000267	0.00334	CcSEcCtD
Granisetron—Arthralgia—Docetaxel—head and neck cancer	0.000264	0.0033	CcSEcCtD
Granisetron—Chest pain—Docetaxel—head and neck cancer	0.000264	0.0033	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000262	0.00327	CcSEcCtD
Granisetron—Hypersensitivity—Fluorouracil—head and neck cancer	0.000258	0.00322	CcSEcCtD
Granisetron—Dry mouth—Docetaxel—head and neck cancer	0.000258	0.00322	CcSEcCtD
Granisetron—Oedema—Docetaxel—head and neck cancer	0.000253	0.00316	CcSEcCtD
Granisetron—Anaphylactic shock—Docetaxel—head and neck cancer	0.000253	0.00316	CcSEcCtD
Granisetron—Infection—Docetaxel—head and neck cancer	0.000251	0.00314	CcSEcCtD
Granisetron—Shock—Docetaxel—head and neck cancer	0.000249	0.00311	CcSEcCtD
Granisetron—Nervous system disorder—Docetaxel—head and neck cancer	0.000248	0.0031	CcSEcCtD
Granisetron—Pruritus—Fluorouracil—head and neck cancer	0.000248	0.0031	CcSEcCtD
Granisetron—Thrombocytopenia—Docetaxel—head and neck cancer	0.000247	0.00309	CcSEcCtD
Granisetron—Tachycardia—Docetaxel—head and neck cancer	0.000247	0.00308	CcSEcCtD
Granisetron—Skin disorder—Docetaxel—head and neck cancer	0.000245	0.00307	CcSEcCtD
Granisetron—Diarrhoea—Fluorouracil—head and neck cancer	0.000239	0.00299	CcSEcCtD
Granisetron—Hypotension—Docetaxel—head and neck cancer	0.000236	0.00295	CcSEcCtD
Granisetron—Dizziness—Fluorouracil—head and neck cancer	0.000231	0.00289	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00023	0.00288	CcSEcCtD
Granisetron—Insomnia—Docetaxel—head and neck cancer	0.000228	0.00286	CcSEcCtD
Granisetron—Paraesthesia—Docetaxel—head and neck cancer	0.000227	0.00284	CcSEcCtD
Granisetron—Dyspnoea—Docetaxel—head and neck cancer	0.000225	0.00282	CcSEcCtD
Granisetron—Somnolence—Docetaxel—head and neck cancer	0.000225	0.00281	CcSEcCtD
Granisetron—Vomiting—Fluorouracil—head and neck cancer	0.000223	0.00278	CcSEcCtD
Granisetron—Dyspepsia—Docetaxel—head and neck cancer	0.000222	0.00278	CcSEcCtD
Granisetron—Rash—Fluorouracil—head and neck cancer	0.000221	0.00276	CcSEcCtD
Granisetron—Dermatitis—Fluorouracil—head and neck cancer	0.00022	0.00276	CcSEcCtD
Granisetron—Decreased appetite—Docetaxel—head and neck cancer	0.00022	0.00275	CcSEcCtD
Granisetron—Headache—Fluorouracil—head and neck cancer	0.000219	0.00274	CcSEcCtD
Granisetron—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000218	0.00273	CcSEcCtD
Granisetron—Pain—Docetaxel—head and neck cancer	0.000216	0.0027	CcSEcCtD
Granisetron—Constipation—Docetaxel—head and neck cancer	0.000216	0.0027	CcSEcCtD
Granisetron—Feeling abnormal—Docetaxel—head and neck cancer	0.000208	0.0026	CcSEcCtD
Granisetron—Nausea—Fluorouracil—head and neck cancer	0.000208	0.0026	CcSEcCtD
Granisetron—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000207	0.00258	CcSEcCtD
Granisetron—Abdominal pain—Docetaxel—head and neck cancer	0.0002	0.0025	CcSEcCtD
Granisetron—Body temperature increased—Docetaxel—head and neck cancer	0.0002	0.0025	CcSEcCtD
Granisetron—Hypersensitivity—Docetaxel—head and neck cancer	0.000186	0.00233	CcSEcCtD
Granisetron—Asthenia—Docetaxel—head and neck cancer	0.000181	0.00227	CcSEcCtD
Granisetron—Pruritus—Docetaxel—head and neck cancer	0.000179	0.00224	CcSEcCtD
Granisetron—Diarrhoea—Docetaxel—head and neck cancer	0.000173	0.00216	CcSEcCtD
Granisetron—Dizziness—Docetaxel—head and neck cancer	0.000167	0.00209	CcSEcCtD
Granisetron—Vomiting—Docetaxel—head and neck cancer	0.000161	0.00201	CcSEcCtD
Granisetron—Rash—Docetaxel—head and neck cancer	0.000159	0.00199	CcSEcCtD
Granisetron—Dermatitis—Docetaxel—head and neck cancer	0.000159	0.00199	CcSEcCtD
Granisetron—Headache—Docetaxel—head and neck cancer	0.000158	0.00198	CcSEcCtD
Granisetron—Nausea—Docetaxel—head and neck cancer	0.00015	0.00188	CcSEcCtD
